Cytosorbents (CTSO) Misses Q2 EPS by 7c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $12 million versus the consensus estimate of $12.27 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Deutsche Bank Upgrades Kingfisher Plc. (KGF:LN) (KGFHY) to Hold
• Citizens Upgrades J.B. Hunt Transport Services (JBHT) to Market Outperform